Jubilant Pharmova Overview
- Year Founded
-
1978
- Status
-
Public
- Employees
-
6,386
- Stock Symbol
-
530019
- Investments
-
16
- Share Price
-
$10.26
- (As of Friday Closing)
Jubilant Pharmova General Information
Description
Jubilant Pharmova Ltd is an integrated pharmaceutical company. The company operates in the following segments; Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Contract Research, Development and Manufacturing Organisation; Generics; and Proprietary Novel Drugs. It generates maximum revenue from the Radiopharma segment which specializes in developing, manufacturing, commercializing, and distributing therapeutic agents in the nuclear medicine domain. Geographically, it derives a majority of its revenue from the Americas and Europe and the rest from India and the Rest of the world.
Contact Information
Website
www.jubilantpharmova.comCorporate Office
- 1A, Sector 16A
- Noida, Uttar Pradesh 201301
- India
Corporate Office
- 1A, Sector 16A
- Noida, Uttar Pradesh 201301
- India
Jubilant Pharmova Stock Performance
As of 13-Nov-2026, Jubilant Pharmova’s stock price is $10.26. Its current market cap is $1.63B with 158M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $10.26 | $10.48 | $8.36 - $13.26 | $1.63B | 158M | 35.3K | $0.18 |
Jubilant Pharmova Financials Summary
As of 30-Sep-2026, Jubilant Pharmova has a trailing 12-month revenue of $967M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 1,939,649 | 1,580,854 | 1,857,565 | 1,387,173 |
| Revenue | 967,396 | 930,823 | 850,560 | 802,649 |
| EBITDA | 123,200 | 139,277 | 181,356 | 94,545 |
| Net Income | 28,365 | 45,098 | 99,270 | 9,313 |
| Total Assets | 1,734,971 | 1,645,180 | 1,491,291 | 1,384,820 |
| Total Debt | 447,199 | 383,105 | 319,268 | 439,363 |
Jubilant Pharmova Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Jubilant Pharmova Comparisons
Industry
Financing
Details
Jubilant Pharmova Competitors (33)
One of Jubilant Pharmova’s 33 competitors is Marksans Pharma, a Corporation company based in Mumbai, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Marksans Pharma | Corporation | Mumbai, India | ||||
| Strides Pharma Science | Formerly VC-backed | Bangalore, India | ||||
| Glenmark Pharmaceuticals | Corporation | Mumbai, India | ||||
| Panacea Biotec | Corporation | New Delhi, India | ||||
| Zydus Lifesciences | Corporation | Ahmedabad, India |
Jubilant Pharmova Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Jubilant Pharmova Patents
Jubilant Pharmova Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3534708-A1 | Synergistic antimicrobial compositions | Inactive | 07-Nov-2016 | ||
| US-20190350200-A1 | Synergistic antimicrobial compositions | Inactive | 07-Nov-2016 | ||
| WO-2018083675-A1 | Synergistic antimicrobial compositions | Inactive | 07-Nov-2016 | ||
| WO-2016092499-A1 | An improved process for the production of quaternary pyridinium salts | Inactive | 12-Dec-2014 | ||
| WO-2015198338-A1 | Synergistic antimicrobial composition of zinc pyrithione | Inactive | 27-Jun-2014 | A01N59/16 |
Jubilant Pharmova Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Jubilant Pharmova Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Jubilant Pharmova Investments & Acquisitions (16)
Jubilant Pharmova’s most recent deal was a Corporate Asset Purchase with Pierre Fabre (Research & Development Centre in Saint-Julien-en-Genevois, France) for . The deal was made on 19-Mar-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Pierre Fabre (Research & Development Centre in Saint-Julien-en-Genevois, France) | 19-Mar-2025 | Corporate Asset Purchase | Buildings and Property | ||
| TruHabit | 01-Apr-2022 | Later Stage VC | Other Consumer Non-Durables | ||
| Safe Foods | 01-Nov-2021 | Corporate | Business/Productivity Software | ||
| Solvay Group (Pyridine Production Assets) | 01-Jan-2021 | Corporate Asset Purchase | Buildings and Property | ||
| Inipharm | 11-Nov-2020 | Early Stage VC | Biotechnology |
Jubilant Pharmova ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
31.29 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Jubilant Pharmova Exits (2)
Jubilant Pharmova’s most recent exit was on 01-Nov-2021 from Safe Foods. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Safe Foods | 01-Nov-2021 | Completed |
|
||
| Insilco | 19-Oct-1988 | Joint Venture | Completed |
|
Jubilant Pharmova Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Cadista Holdings | Yardley, PA | 1988 | |
| HollisterStier Allergy | Spokane, WA | 1921 | |
| Jubilant Radiopharma | Yardley, PA |
Jubilant Pharmova FAQs
-
When was Jubilant Pharmova founded?
Jubilant Pharmova was founded in 1978.
-
Where is Jubilant Pharmova headquartered?
Jubilant Pharmova is headquartered in Noida, India.
-
What is the size of Jubilant Pharmova?
Jubilant Pharmova has 6,386 total employees.
-
What industry is Jubilant Pharmova in?
Jubilant Pharmova’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Jubilant Pharmova a private or public company?
Jubilant Pharmova is a Public company.
-
What is Jubilant Pharmova’s stock symbol?
The ticker symbol for Jubilant Pharmova is 530019.
-
What is the current stock price of Jubilant Pharmova?
As of 13-Nov-2026 the stock price of Jubilant Pharmova is $10.26.
-
What is the current market cap of Jubilant Pharmova?
The current market capitalization of Jubilant Pharmova is $1.63B.
-
What is Jubilant Pharmova’s current revenue?
The trailing twelve month revenue for Jubilant Pharmova is $967M.
-
Who are Jubilant Pharmova’s competitors?
Marksans Pharma, Strides Pharma Science, Glenmark Pharmaceuticals, Panacea Biotec, and Zydus Lifesciences are some of the 33 competitors of Jubilant Pharmova.
-
What is Jubilant Pharmova’s annual earnings per share (EPS)?
Jubilant Pharmova’s EPS for 12 months was $0.18.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
